Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy. 2001

B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
Steno Diabetes Center, Gentofte, Denmark.

OBJECTIVE We studied the effect of a diet supplementation with fish oil in insulin-dependent diabetic patients with nephropathy in order to evaluate whether abnormal transcapillary escape rate of albumin and procoagulant activity in these patients could be modified. METHODS A double-blind, randomized, controlled study was carried out at a tertiary referral centre. The subjects were 29 insulin-dependent diabetic patients with nephropathy. One year of fish oil supplementation (4.6 g n-3 fatty acids/day) was compared with placebo (olive oil). The main outcome measures were N-3 fatty acid proportions of platelet lipids, transcapillary escape rate of albumin, prothrombin fragment 1 + 2, thrombin-antithrombin complexes, markers of fibrinolysis, fibrinogen, factor VII antigen and activity, thrombomodulin, von Willebrand factor, platelet factor 4 and beta-thromboglobulin. These were measured every 6 months. RESULTS Neither transcapillary escape rate of albumin (7.4 (median) (5.0-9.8) (range) % vs. 7.0 (4.6-10.6) %) nor prothrombin fragment 1 + 2 (0.97 (0.72-2.40) nmol/L vs. 1.01 (0.59-3.11) nmol/L) changed after 12 months of fish oil supplementation. CONCLUSIONS Increased transcapillary escape rate of albumin and activity could not be modified during diet supplementation with fish oil in insulin-dependent diabetic patients with nephropathy.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D010938 Plant Oils Oils derived from plants or plant products. Oils, Plant,Oils, Vegetable,Plant Oil,Vegetable Oil,Vegetable Oils,Oil, Plant,Oil, Vegetable
D010978 Platelet Factor 4 A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C. Antiheparin Factor,CXCL4 Chemokine,Chemokine CXCL4,Heparin Neutralizing Protein,PF4 (Platelet Factor 4),gamma-Thromboglobulin,CXCL4, Chemokine,Chemokine, CXCL4,gamma Thromboglobulin
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte

Related Publications

B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
May 1986, Diabetologia,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
November 1985, Diabetologia,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
January 1993, Diabetologia,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
January 1995, Diabetes care,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
June 1997, Diabetes care,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
February 1988, The Medical journal of Australia,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
June 1983, Clinical physiology (Oxford, England),
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
January 1988, Diabetic medicine : a journal of the British Diabetic Association,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
February 1974, Scandinavian journal of clinical and laboratory investigation,
B Myrup, and P Rossing, and T Jensen, and H H Parving, and G Hølmer, and J Gram, and C Kluft, and J Jespersen
May 2000, Medical oncology (Northwood, London, England),
Copied contents to your clipboard!